Wird geladen...
Serum free IgE guided dose reduction of omalizumab: a case report
BACKGROUND: Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at treatment step 5 that is used for severe asthma patients who are allergic to perenn...
Gespeichert in:
| Veröffentlicht in: | Allergy Asthma Clin Immunol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5577842/ https://ncbi.nlm.nih.gov/pubmed/28861109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-017-0211-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|